New Breastlight Data Confirms Accuracy in Detecting Malignant Tumors

Photography of Breastlight taken at Sunderland trial. Shadow on left breast represents increased blood supply (angiogenesis) associated with tumor growth. Confirmed by biopsy as malignant tumor of 2.2 cm. Right breast with no shadow confirmed as negative.


June 17, 2010 – Breastlight successfully detects malignant tumors and picks up lesions as small as 7 mm, according to data presented this week at the European Institute of Oncology's 12th Milan Breast Cancer Conference. [1]

The handheld device, for women to use at home, was tested in a trial at a breast clinic in Sunderland City Hospital involving 300 women. Patients were examined with Breastlight and findings compared to mammography, ultrasound and biopsy.

Breastlight detected 12 out of 18 confirmed malignant tumors, and correctly identified as negative 240 out of 282 breasts. [1] The device also detected malignant tumors as small as 7 mm. [1] Malignancies below 1.8 cm are considered non-palpable. [2]

“We were impressed with the sensitivity and specificity of the Breastlight device,” said Matei Dordea, specialist registrar at Sunderland City Hospital. “Mammography sensitivity falls between 60 and 90 percent and specificity falls between 75 and 95 percent. Breastlight’s sensitivity was 67 percent with specificity at 85 percent. We are not saying that Breastlight could replace mammography, but it can reliably pick up abnormal lumps which can be investigated to assess whether benign or malignant.”

The Sunderland team see Breastlight’s role in women who find palpation difficult: “Women who have confirmed recurrent cysts find it difficult to palpate. As benign cysts tend not to have a blood supply, they will not show up with Breastlight. However, if women feel new cysts they should always seek medical advice.”

Breastlight is a UK invention that works by shining a very bright but harmless red LED light through breast tissue. Veins and other blood vessels show up as dark lines, often referred to as the “map” of the breast. This is normal. If a woman detects dark spots or shadows, this is generally an indication that there is an abnormality. This could be the stimulation of blood vessels (angiogenesis) when a tumor is developing or a benign lesion such as a bruise or blood-filled cyst.

For more information: www.breastlight.com

References:

1. Iwuchukwu, O., Keaney, N., Dordea, M. “Analysis of Breastlight findings in patients with biopsies.” City Hospital Sunderland. Presentation given at the European Institute of Oncology’s 12th Milan Breast Cancer Conference
2. Canadian Cancer Society


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

GRACE Breast Imaging & Medical Spa of Iowa, with locations in Urbandale and Clive, recently became the first healthcare ...

Time January 24, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
Subscribe Now